SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-015047
Filing Date
2024-04-17
Accepted
2024-04-17 17:00:25
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 319877
2 ex31-1.htm EX-31.1 6182
3 ex31-2.htm EX-31.2 6158
4 ex31-3.htm EX-31.3 6241
  Complete submission text file 0001493152-24-015047.txt   592874

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cocp-20231231.xsd EX-101.SCH 3036
6 XBRL LABEL FILE cocp-20231231_lab.xml EX-101.LAB 36884
7 XBRL PRESENTATION FILE cocp-20231231_pre.xml EX-101.PRE 24160
19 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 6422
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38418 | Film No.: 24851829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)